Why Viking Therapeutics Stock Rocked the Market Today

a week ago

The biotech continued to get attention from both pundits and investors, thanks largely to its investigational obesity drug.

Ticker	Sentiment	Impact
VKTX	Bullish	53 %
NVO	Neutral	14 %